Goel V - Search Results

1

A role for ATF2 in regulating MITF and melanoma development.

Shah M, Bhoumik A, Goel V, Dewing A, Breitwieser W, Kluger H, Krajewski S, Krajewska M, Dehart J, Lau E, Kallenberg DM, Jeong H, Eroshkin A, Bennett DC, Chin L, Bosenberg M, Jones N, Ronai ZA. Shah M, et al. Among authors: goel v. PLoS Genet. 2010 Dec 23;6(12):e1001258. doi: 10.1371/journal.pgen.1001258. PLoS Genet. 2010. PMID: 21203491 Free PMC article.

2

Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.

Goel VK, Ibrahim N, Jiang G, Singhal M, Fee S, Flotte T, Westmoreland S, Haluska FS, Hinds PW, Haluska FG. Goel VK, et al. Oncogene. 2009 Jun 11;28(23):2289-98. doi: 10.1038/onc.2009.95. Epub 2009 Apr 27. Oncogene. 2009. PMID: 19398955 Free PMC article.

3

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG. Goel VK, et al. J Invest Dermatol. 2006 Jan;126(1):154-60. doi: 10.1038/sj.jid.5700026. J Invest Dermatol. 2006. PMID: 16417231 Free article.

4

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

Tsao H, Goel V, Wu H, Yang G, Haluska FG. Tsao H, et al. Among authors: goel v. J Invest Dermatol. 2004 Feb;122(2):337-41. doi: 10.1046/j.0022-202X.2004.22243.x. J Invest Dermatol. 2004. PMID: 15009714 Free PMC article.

5

PTEN signaling pathways in melanoma.

Wu H, Goel V, Haluska FG. Wu H, et al. Among authors: goel v. Oncogene. 2003 May 19;22(20):3113-22. doi: 10.1038/sj.onc.1206451. Oncogene. 2003. PMID: 12789288 Review.

6

Genetic alterations in signaling pathways in melanoma.

Haluska FG, Tsao H, Wu H, Haluska FS, Lazar A, Goel V. Haluska FG, et al. Among authors: goel v. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2301s-2307s. doi: 10.1158/1078-0432.CCR-05-2518. Clin Cancer Res. 2006. PMID: 16609049 Review.

7

Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes.

Goel VK, Li X, Chen H, Liu SC, Chishti AH, Oh SS. Goel VK, et al. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5164-9. doi: 10.1073/pnas.0834959100. Epub 2003 Apr 11. Proc Natl Acad Sci U S A. 2003. PMID: 12692305 Free PMC article.

8

Erythrocyte calpain is dispensable for malaria parasite invasion and growth.

Hanspal M, Goel VK, Oh SS, Chishti AH. Hanspal M, et al. Mol Biochem Parasitol. 2002 Jul;122(2):227-9. doi: 10.1016/s0166-6851(02)00104-4. Mol Biochem Parasitol. 2002. PMID: 12106878 No abstract available.

9

Biomechanical analysis of a trans-discal, multi-level stabilization screw (MLSS) at the upper instrumented vertebra (UIV) of long posterior thoracolumbar instrumentations.

Collins AP, Shah AA, Shekouhi N, Goel VK, Theologis AA. Collins AP, et al. Among authors: goel vk. Spine Deform. 2024 Apr 5. doi: 10.1007/s43390-024-00862-7. Online ahead of print. Spine Deform. 2024. PMID: 38578598

10

Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.

Pecci F, Nakazawa S, Ricciuti B, Harada G, Lee JK, Alessi JV, Barrichello A, Vaz VR, Lamberti G, Di Federico A, Gandhi MM, Gazgalis D, Feng WW, Jiang J, Baldacci S, Locquet MA, Gottlieb FH, Chen MF, Lee E, Haradon D, Smokovich A, Voligny E, Nguyen T, Goel VK, Zimmerman Z, Atwal S, Wang X, Bahcall M, Heist RS, Iqbal S, Gandhi N, Elliott A, Vanderwalde AM, Ma PC, Halmos B, Liu SV, Che J, Schrock AB, Drilon A, Janne PA, Awad MM. Pecci F, et al. Among authors: goel vk. Cancer Discov. 2024 Apr 3. doi: 10.1158/2159-8290.CD-23-1217. Online ahead of print. Cancer Discov. 2024. PMID: 38564707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

877 results

Search Page